AKT2 and familial pancreatic carcinoma: AKT2 amplification is frequently detected in various tumors, including ovarian, breast, colorectal, and pancreatic cancers, and is positively correlated with increased invasion and poor prognosis (Bellacosa et al., 1995; Parsons et al., 2005; Cheng et al., 1996).